Sale

Travel Vaccines Market

Global Travel Vaccines Market Size, Trends, Forecast: By Composition: Mono Vaccines, Combination Vaccines; By Disease: Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Others; Regional Analysis; Matkey Dynamics: SWOT Analysis, Porter’s Five Forces Model; Supplier Landscape; 2024-2032

Global Travel Vaccines Market Outlook 

The global travel vaccines market size attained a value of about USD 3.87 billion in 2023, driven by rising prevalence of infectious and travel-related diseases such as Japanese encephalitis, meningitis, diphtheria, and yellow fever. The market is further expected to grow at a CAGR of 10.7% during the forecast period of 2024-2032 to reach nearly USD 9.67 billion by 2032.

 

Global Travel Vaccines Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

On the basis of the composition, the combination vaccines segment accounted for the majority of the global travel vaccines market share, as it protects the travellers against multiple diseases. Based on the disease, the hepatitis A segment dominated the industry in 2020. Regionally, North America held the most significant market share in 2020, on account of the presence of a large number of companies in the region who are introducing a superior range of travel vaccines.

 

Properties and Applications

Travel vaccines are immunization shots, which travellers get before visiting any region across the world. These vaccines build immunity against viral as well as microbial invasions while improving the overall health of the individual. In addition, the body responds to the vaccination by making antibodies and protecting it against a situation where there is an exposure to the disease. These immunizations must be taken at least 4 to 6 weeks before travelling as this gives enough time for the immunization to start working efficiently.

 

Global Travel Vaccines Market By Composition

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The major compositions of the global travel vaccines market are:

  • Mono Vaccines
  • Combination Vaccines

The industry can be broadly categorised on the basis of the diseases segment into:

  • Hepatitis A 
  • DPT
  • Yellow Fever
  • Typhoid
  • Hepatitis B
  • Measles and Mumps
  • Rabies
  • Meningococcal
  • Varicella
  • Japanese Encephalitis
  • Others

The EMR report looks into the regional markets in the global travel vaccines market like North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa.

 

Global Travel Vaccines Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The rising prevalence of infectious and travel-related diseases, such as Japanese encephalitis, meningitis, diphtheria, and yellow fever, is one of the prime factors that are driving the growth of the industry. In addition to this, the rising globalization and reduced international airfares have led to an increase in international tourism. Consequently, travel vaccines have now become an important requirement in an international travellers’ list, with its market witnessing a significant growth globally. Several combination vaccines have also been introduced for travellers, which protect against more than one disease, thus, supporting the industry growth as they increasingly gain popularity. Additionally, governments across several countries are heavily investing in the promotion of the use of these vaccines. For instance, the Ministry of Health in the Kingdom of Saudi Arabia (KSA) requires that all travellers arriving for Hajj and Umrah from other countries must present a valid vaccination certificate. Other factors driving the demand for travel vaccines include increasing awareness levels, technological advancements, and increasing incidences of life-threatening infectious diseases.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global travel vaccines market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • GlaxoSmithKline plc.
  • Merck & Co., Inc 
  • Sanofi
  • Pfizer Inc.
  • CSL Limited
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Composition
  • Disease
  • Region
Breakup by Composition
  • Mono Vaccines
  • Combination Vaccines
Breakup by Disease
  • Hepatitis A
  • DPT
  • Yellow Fever
  • Typhoid
  • Hepatitis B
  • Measles and Mumps
  • Rabies
  • Meningococcal
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • GlaxoSmithKline plc.
  • Merck & Co.,
  • Sanofi SA
  • Pfizer Inc.
  • CSL Limited
  • Bavarian Nordic
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • AstraZeneca plc
  • Bavarian Nordic
  • Crucell
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Travel Vaccine Market Overview 

    3.1    Global Travel Vaccine Market Historical Value (2017-2023) 
    3.2    Global Travel Vaccine Market Forecast Value (2024-2032)
4    Global Travel Vaccine Market Landscape
    4.1    Global Travel Vaccine Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Travel Vaccine Product Landscape
        4.2.1    Analysis by Composition
        4.2.2    Analysis by Disease
5    Global Travel Vaccine Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Travel Vaccine Market Segmentation 
    6.1    Global Travel Vaccine Market by Composition
        6.1.1    Market Overview
        6.1.2    Mono Vaccines
        6.1.3    Combination Vaccines
    6.2    Global Travel Vaccine Market by Disease
        6.2.1    Market Overview
        6.2.2    Hepatitis A
        6.2.3    DPT
        6.2.4    Yellow Fever
        6.2.5    Typhoid
        6.2.6    Hepatitis B
        6.2.7    Measles and Mumps
        6.2.8    Rabies
        6.2.9    Meningococcal
        6.2.10    Others
    6.3    Global Travel Vaccine Market by Region
        6.3.1    Market Overview
        6.3.2    North America 
        6.3.3    Europe
        6.3.4    Asia Pacific
        6.3.5    Latin America
        6.3.6    Middle East and Africa
7    North America Travel Vaccine Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Travel Vaccine Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Travel Vaccine Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Travel Vaccine Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Travel Vaccine Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding and Investment Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    GlaxoSmithKline plc.
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Merck & Co.,
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Sanofi SA
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Pfizer Inc.
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    CSL Limited
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Bavarian Nordic
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    F. Hoffmann-La Roche Ltd
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Abbott Laboratories
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    AstraZeneca plc
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Bavarian Nordic
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Crucell
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
18    Global Travel Vaccine Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the market attained a value of approximately USD 3.87 billion.

The market is anticipated to grow at a CAGR of 10.7% during the forecast period of 2024-2032 to reach a value of USD 9.67 billion by 2032.

The major drivers of the industry, such as rising globalization, rising prevalence of infectious and travel-related diseases such as Japanese encephalitis, meningitis, diphtheria, and yellow fever, are expected to aid the market growth.

The key industry trend guiding the growth of the travel vaccines market includes the promotion of different vaccines by the government bodies of several countries.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest market share.

The combination vaccines segment is the leading travel vaccine composition in the industry.

The hepatitis A segment is the dominant disease-type in the industry.

The major players in the industry are GlaxoSmithKline plc., Merck & Co., Inc, Sanofi, Pfizer Inc., and CSL Limited, among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER